Home
Solara Active Pharma Sciences Ltd Quarterly Result

Solara Active Pharma Sciences Ltd
NSE: SOLARA
Net Profit - Last Quarter
Solara Active Pharma Sciences Ltd Quarterly Results Key Highlights
- The revenue of Solara Active Pharma Sciences Ltd for the Dec '24 is ₹ 301.8 crore as compare to the Sep '24 revenue of ₹ 347.27 crore.
- This represent the decline of -13.09%a1# The ebitda of Solara Active Pharma Sciences Ltd for the Dec '24 is ₹ 59.17 crore as compare to the Sep '24 ebitda of ₹ 61.63 crore.
- This represent the decline of -3.99%a1# The net profit of Solara Active Pharma Sciences Ltd for the Dec '24 is ₹ 8.09 crore as compare to the Sep '24 net profit of ₹ 8.01 crore.
- This represent the growth of 1%a1#.
Solara Active Pharma Sciences Ltd Quarterly Results Analysis
Market Price of Solara Active Pharma Sciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
28 Apr 2025 | 514.65 |
25 Apr 2025 | 509.4 |
24 Apr 2025 | 533.95 |
23 Apr 2025 | 518.4 |
22 Apr 2025 | 522.75 |
21 Apr 2025 | 521.15 |
17 Apr 2025 | 522.85 |
16 Apr 2025 | 519.05 |
15 Apr 2025 | 518.15 |
11 Apr 2025 | 510.1 |
Historical Revenue of Solara Active Pharma Sciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Solara Active Pharma Sciences Ltd
Historical EBITDA of Solara Active Pharma Sciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Solara Active Pharma Sciences Ltd
Historical Net Profit of Solara Active Pharma Sciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Ltd News Hub
Solara Active Pharma Sciences schedules AGM
Solara Active Pharma Sciences announced that the Annual General Meeting (AGM) of the company will be
Read more
30 Aug 24
Solara Active Pharma Sciences to incorporate wholly owned subsidiary
Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to p
Read more
07 Feb 25
Solara Active Pharma Sciences reports consolidated net profit of Rs 8.01 crore in the September 2024 quarter
Net profit of Solara Active Pharma Sciences reported to Rs 8.01 crore in the quarter ended September
Read more
21 Oct 24
Solara Active Pharma Sciences allots 49,000 equity shares under ESOP
Solara Active Pharma Sciences has allotted 49,000 equity shares under ESOP on 21 October 2024. Power
Read more
21 Oct 24